|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Ginkgo Bioworks Holdings (NYSE: DNA) through any online brokerage.
There are no as such competitors for Ginkgo Bioworks Holdings.
The latest price target for Ginkgo Bioworks Holdings (NYSE: DNA) was reported by Raymond James on October 13, 2021. The analyst firm set a price target for 14.50 expecting DNA to rise to within 12 months (a possible 1.54% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Ginkgo Bioworks Holdings (NYSE: DNA) is $14.28 last updated Mon Oct 25 2021 19:59:57 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings’s $Q3 earnings are confirmed for after-market on $November 5, 2021.
There is no upcoming split for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.